Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China
Conditions: Breast Cancer; Neoadjuvant Therapy; Neoplasm Staging; Estrogen Receptor; Histological Grade; HER2; Prognosis; Predictive Value of Tests Intervention: Sponsor: Peking University First Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials